KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

McEwen (MUX) Other Non-Current Assets (2016 - 2025)

McEwen has reported Other Non-Current Assets over the past 14 years, most recently at $34000.0 for Q4 2025.

  • Quarterly results put Other Non-Current Assets at $34000.0 for Q4 2025, down 66.67% from a year ago — trailing twelve months through Dec 2025 was $34000.0 (down 66.67% YoY), and the annual figure for FY2025 was $34000.0, down 66.67%.
  • Other Non-Current Assets for Q4 2025 was $34000.0 at McEwen, down from $36000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for MUX hit a ceiling of $4.5 million in Q4 2023 and a floor of $34000.0 in Q4 2025.
  • Median Other Non-Current Assets over the past 5 years was $2.0 million (2022), compared with a mean of $2.2 million.
  • Peak annual rise in Other Non-Current Assets hit 493.76% in 2025, while the deepest fall reached 98.82% in 2025.
  • McEwen's Other Non-Current Assets stood at $711000.0 in 2021, then skyrocketed by 434.04% to $3.8 million in 2022, then increased by 18.25% to $4.5 million in 2023, then plummeted by 97.73% to $102000.0 in 2024, then crashed by 66.67% to $34000.0 in 2025.
  • The last three reported values for Other Non-Current Assets were $34000.0 (Q4 2025), $36000.0 (Q3 2025), and $4.0 million (Q2 2025) per Business Quant data.